VKH
XBIT icon

Virtu KCG Holdings’s XBiotech XBIT Stock Holding History

Virtu KCG Holdings’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$63K Buy
13,379
+2,081
+18% +$19.9K ﹤0.01% 2535
2017
Q1 		$186K Buy
+11,298
New +$148K 0.01% 2474
2016
Q1 		– Sell
-10,410
Closed -$113K – 3757
2015
Q4 		$113K Buy
+10,410
New +$133K ﹤0.01% 2961
2015
Q3 		– Sell
-26,366
Closed -$477K – 3874
2015
Q2 		$477K Buy
+26,366
New +$547K 0.01% 1537

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Virtu KCG Holdings's XBIT Position: Q2 2017 in Review

Virtu KCG Holdings increased its XBiotech (XBIT) stake by 18% in Q2 2017, buying an estimated $19.9K and bringing the position to 13,379 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #2535.

Virtu KCG Holdings first reported a position in XBIT in Q2 2015 and has held it in 4 quarters since. The position peaked at $477K in Q2 2015. 46 funds tracked by Wall St. Rank hold XBIT as of Q2 2017.

  • Virtu KCG Holdings held 13,379 shares of XBiotech worth $63K as of Q2 2017.
  • Virtu KCG Holdings bought 2,081 XBiotech shares in Q2 2017, an estimated $19.9K.
  • XBiotech made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2535 holding.
  • Virtu KCG Holdings first reported a position in XBiotech in Q2 2015 and has held it in 4 quarters since.
  • Virtu KCG Holdings's XBiotech position peaked at $477K in Q2 2015.
  • 46 funds tracked by Wall St. Rank held XBiotech as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.